Results 181 to 190 of about 82,336 (259)

Comparison of BAFF and type I IFN activity in blood and placenta in SLE and healthy pregnancies. [PDF]

Lupus Sci Med
Torell A, Andersson K, Gunnarsson I, Svenungsson E, Zickert A, Majczuk Sennström M, Trysberg E, Bengtsson AA, Jönsen A, Strevens H, Sjöwall C, Saleh M, Pihl S, Leonard D, Ronnblom L, Akhter T, Roshanzamir F, Zetterberg H, Bylund J, Jacobsson B, Rudin A, Lundell AC, Stockfelt M.   +22 more
europepmc   +1 more source

TRIM Expression and Its Association With Disease Activity in Systemic Lupus Erythematosus

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse manifestations, including rash, arthritis, and nephritis. Although autoantibodies are a key feature of SLE, their levels often poorly reflect disease severity, suggesting the involvement of additional contributing factors.
Ling‐Ying Lu, Ling‐Jung Yen, Hui‐Ling Hsia, Zi‐Xeng Weng, Chi‐Hsiang Chung, Paul Wei‐Che Hsu, Chih‐Wei Chiu, Wu‐Chien Chien, Tsung‐Hsien Chang   +8 more
wiley   +1 more source

Targeting mTOR in Systemic Lupus Erythematosus: From Immune Cell Dysfunction to Clinical Translation. [PDF]

J Inflamm Res
Jiang X, Sun L, Ji J, Zhao C, Wang Y, Zhang H, Wu Q, Su Q, Li F, Zhang S, Cheng T.   +10 more
europepmc   +1 more source

Impact of Co‐Morbid Immunocompromise in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma

The Laryngoscope, EarlyView.
Among patients with surgically resected Human Papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), immunocompromised patients had significantly worse overall survival compared to the non‐compromised group; however, these exploratory findings should be interpreted cautiously.
Maxwell L. Weng, Tereza Vitkovska, Song Hon Hwang, Lauran K. Evans, Hong‐Ho Yang, Christopher Dann, Dipti Sajed, Maie A. St. John   +7 more
wiley   +1 more source

Second-look endoscopy does not reduce delayed bleeding after endoscopic papillectomy: a multicenter propensity score-matched analysis. [PDF]

Ther Adv Gastroenterol
Fujii Y, Matsumoto K, Ueki T, Himei H, Sakakihara I, Ueta E, Toyokawa T, Harada R, Ogawa T, Tomoda T, Kato H, Mitsuhashi T, Sato R, Matsumi A, Miyamoto K, Uchida D, Horiguchi S, Tsutsumi K, Otsuka M.   +18 more
europepmc   +1 more source

Investigating Polyethylene Solubility for Solvent-Based Recycling: Experiments and SAFT‑γ Mie Predictions. [PDF]

Macromolecules
Standish R, Yin J, Burger J, Jackson G, Adjiman CS, Minceva M, Galindo A.   +6 more
europepmc   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

Phytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee, Yu Jin So, Il‐Joo Jo, Ji Yong Jang, Tae Han Yook, Jun Ho Lee, Sung Wook Kim, Kangwook Lee, Soo Jung Park, Gabsik Yang   +9 more
wiley   +1 more source

Age‐related clinical heterogeneity and peripheral T cell profile alterations in primary Sjögren's disease: A retrospective study of 5778 patients

Rheumatology &Autoimmunity, EarlyView.
This large‐scale retrospective study of 5778 primary Sjögren's disease (SjD) patients, stratified by diagnostic age, defines a distinct clinical and immunological profile for early‐diagnosed (<45 years) disease. We identified early diagnosis as an independent risk factor for hypergammaglobulinemia and interstitial lung disease, underpinned by a ...
Yuan Ning, Ruiling Feng, Kai Zhang, Yipeng Han, Ruoyi Wang, Guangwen Li, Yuebo Jin, Jing He   +7 more
wiley   +1 more source

A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus. [PDF]

J Transl Autoimmun
Renaudineau Y, Hedrich CM, Guery JC, Miyara M, Damoiseaux J, Mouthon L, Pugnet G, Faguer S, Delpuech A, Bellière J, Sailler L, Puissant B, Fusaro M.   +12 more
europepmc   +1 more source

Anti-Type I Interferon Autoantibodies in COVID-19 and Systemic Lupus Erythematosus: A Comparative Review. [PDF]

Antibodies (Basel)
Lim XR, Teo RXW, Par RYX, Leung BPL.
europepmc   +1 more source